Brandinium

Trademark search for:

VALINJECT

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-07-06 — Application filed
  • 2017-02-16 — Sn assigned for sect 66a appl from ib
  • 2017-02-17 — Application filed
  • 2017-02-17 — Assigned to examiner
  • 2017-02-21 — Application filed
  • 2017-02-21 — Final disposition recorded
  • 2017-02-22 — Office action issued
  • 2017-02-22 — Office action issued
  • 2017-02-22 — Office action issued
  • 2017-03-11 — Office action issued
  • 2017-08-22 — Office action issued
  • 2017-09-05 — Assigned to lie
  • 2017-09-07 — Correspondence received in law office
  • 2017-09-07 — Teas/email correspondence entered
  • 2017-09-25 — Office action issued
  • 2017-09-25 — Office action issued
  • 2017-09-25 — Office action issued
  • 2018-03-26 — Exparte appeal received at ttab
  • 2018-03-26 — Jurisdiction restored to examining attorney
  • 2018-03-26 — Ex parte appeal-instituted
  • 2018-03-26 — Teas request for reconsideration received
  • 2018-03-26 — Teas change of correspondence received
  • 2018-03-27 — Correspondence received in law office
  • 2018-03-27 — Teas/email correspondence entered
  • 2018-04-12 — Examiners amendment -written
  • 2018-04-12 — Examiners amendment e-mailed
  • 2018-04-12 — Notification of examiners amendment e-mailed
  • 2018-04-12 — Examiner's amendment entered
  • 2018-04-27 — Approved for pub - principal register
  • 2018-04-30 — Exparte appeal terminated
  • 2018-05-16 — Notice of start of opposition period created, to be sent to ib
  • 2018-05-16 — Notification of notice of publication e-mailed
  • 2018-05-16 — Notification of possible opposition sent to ib
  • 2018-06-01 — Notification processed by ib
  • 2018-06-05 — Published for opposition
  • 2018-06-05 — Official gazette publication confirmation e-mailed
  • 2018-07-18 — Notification of possible opposition created, to be sent to ib
  • 2018-07-18 — Notification of possible opposition sent to ib
  • 2018-08-03 — Notification of possible opposition - processed by ib
  • 2018-08-21 — Registered-principal register
  • 2018-11-21 — Final disposition recorded
  • 2018-12-01 — Final disposition recorded
  • 2018-12-01 — Final disposition recorded
  • 2018-12-21 — Final disposition recorded
  • 2019-11-21 — New representative at ib received
  • 2021-03-12 — Change of owner received from ib
  • 2021-11-26 — New representative at ib received
  • 2023-08-21 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2023-11-04 — New representative at ib received
  • 2025-03-07 — Cancelled section 71
  • 2025-03-07 — Final status recorded
  • 2025-11-07 — Total invalidation of reg ext protection created

Owner Information

EVER Valinject GmbH
AT
EVER Neuro Pharma GmbH
AT
EVER Neuro Pharma GmbH
AT
EVER Neuro Pharma GmbH
AT

Correspondent

MATTHEW D ASBELL LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
UNITED STATES

Filing Details

Filing Date:
2016-07-06
Status Date:
2025-03-07
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.